This manual offers best practices to states, tribes, and local communities on collaborative treatment approaches for pregnant women living with opioid use disorders, and the risks and benefits associated with medication-assisted treatment.
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal...
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants This Clinical Guide provides comprehensive, national guidance for optimal...
Addressing Viral Hepatitis in People With Substance Use Disorders This quick guide helps clinicians address viral hepatitis when working with...
Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders This manual offers guidelines for medication-assisted treatment for people,...
Federal Guidelines for Opioid Treatment Programs This manual provides guidelines for the operation of opioid treatment programs....
TIP 63: Medications for Opioid Use Disorder – Introduction to Medications for Opioid Use Disorder Treatment (Part 1 of 5) Part 1 of this Treatment Improvement Protocol (TIP) offers a general...
SAMHSA's mission is to reduce the impact of substance abuse and mental illness on
America's communities.
5600 Fishers Ln • Rockville, MD 20857
1-877-SAMHSA-7 (1-877-726-4727)
